<DOC>
	<DOCNO>NCT01558635</DOCNO>
	<brief_summary>Studies show take drug stay AF limit success . This research design study heart rhythm surgical therapy , namely measure benefit surgery treat Atrial Fibrillation ( AF ) Cardioblate CryoFlex Surgical Ablation System . The system approve commercially available CE mark . The purpose study support evidence Cardioblate System safe effective treat AF .</brief_summary>
	<brief_title>Safety Efficacy Cryothermia Treat Longstanding Persistent Atrial Fibrillation ( AF )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients must document history longstanding persistent AF define HRS/EHRA/ECAS Guidelines Patients concomitant indication ( AF ) openheart surgery mitral valve repair replacement ( bioprosthesis ) Patients old equal 18 year age Atrioventricular reentrant tachycardia ( AVRT ) NYHA Class = IV Left ejection fraction â‰¤ 30 % Need emergent cardiac surgery ( i.e . cardiogenic shock ) redo open heart surgery Previous atrial fibrillation ablation , AVnodal ablation , surgical Maze procedure Contraindication anticoagulation therapy Left atrial diameter &gt; 7.0 cm Preoperative need intraaortic balloon pump intravenous inotropes Renal failure require dialysis hepatic failure Life expectancy less one year Pregnancy desire pregnant within 12 month study treatment Current diagnosis active systemic infection Documented MI 6 week prior study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Surgical ablation</keyword>
	<keyword>Maze procedure</keyword>
	<keyword>AF</keyword>
</DOC>